[2P-0588] Effect of serum on immunoassay of aggregates of amyloid beta protein

〇Masaya Otsuki¹, Akira Itakura¹, Hideki Kohno², Kazuaki Yoshimune¹ (1.Dept.of Appl. Mol. Chem., Coll. Ind. Tech., Nihon Univ., 2.Hoshi Univ.)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[2P-0589] Impaired hippocampal neurogenesis in App-knock-in model mice of Alzheimer’s disease

〇Guianfranco Mazzei¹, Erika Castillo¹, Kunihiko Sakumi¹, Takashi Saito², Takaomi C. Saido², Yusaku Nakabeppu¹ (1.Division of Neurofunctional Genomics, Medical Institute of Bioregulation, Kyushu University, Japan, 2.Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Japan)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[2P-0590] s Cst-3 p3 peptide a candidate for a CSF biomarker of Alzheimer´s disease?

〇Fujiya Gomi¹, Yoko Uchida¹, Shogo Endo¹ (1.Tokyo Metropolitan Inst. Gerontology)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[2P-0591] Amyloid-β accumulation-inhibiting protein ILEI/FAM3Cː neuronal expression and its reduction in Alzheimer′s disease

〇Naoki Watanabe¹, Lei Liu¹, Hiroyasu Akatsu², Masaki Nishimura¹ (1.MNRC, Shiga Univ. of Med. Sci., 2.Choju Medical Institute, Fukushimura Hospital)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[2P-0592(1AS19-5)] Inactivation of NF-Y induces differential, cell type-specific neuropathologies in the CNS

〇Tomoyuki Yamanaka¹, Nobuyuki Nukina¹ (1.Doshisha Univ. Grad. Sch. of Brain Sci)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[2P-0593] Mechanism for accumulation of abnormal prion protein in prion diseases

〇Keiji Uchiyama¹, Suehiro Sakaguchi¹ (1.Inst. for Enz. Res., Tokushima Univ.)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[2P-0594] LMTK3 deficiency causes schizophrenia-related behaviour in mice

〇Kristopher Montrose¹, Tadashi Yamamoto¹ (1.Okinawa Institute of Science and Technology)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[2P-0595(1AS19-4)] Molecular mechanism of PARK9 and lysosomal dysfunction

〇Shigeto Sato¹, Masato Koike¹, Manabu Funayama¹, Sachiko Noda¹, Junji Ezaki², Takahiro Fukuda³, Takashi Ueno¹, Yasuo Uchiyama¹, Nobutaka Hattori¹ (1.Univ. of Juntendo, 2.Transl. Res. C., Fukushima Med. Sch., 3.Dept. of Neuropath., The Jikei Univ. Sch. of Med.)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[2P-0596] Involvement of exosomes in degeneration of dopaminergic neurons in drug-induced Parkinsonʼs disease model

〇Reiho Tsutsumi¹, Takahiro Seki¹, Mutsumi Oshima¹, Yuki Kurauchi¹, Akinori Hisatsune^2,3, Hiroshi Katsuki¹ (1.Dept. Chemico-Pharmacol. Sci., Grad. Sch. pharm. Sci., Kumamoto Univ., 2.Priority Organization for Innovation and Excellence, Kumamoto Univ., 3.Program for Leading Grad. Sch. \"HIGO Program\", Kumamoto Univ)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[2P-0597] Paraquat impairs the anti-oxidative stress activity of DJ-1 by the formation of SDS-resistant DJ-1 dimer.

〇Tatsuki Yasuda¹, Hiroyoshi Ariga², Sanae M.M. Iguchi-Ariga¹ (1.Grad. Sch. of Life Sci., Univ. of Hokkaido, 2.Grad. Sch. of Pharm., Univ. of Hokkaido)

The 39th Annual Meeting of the Molecular Biology Society of Japan